BioPharma Resources

Drug Trial Radar · NCT03590366

A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea

A Vehicle-Controlled, Double-Blind, Randomized Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Mild to Moderate Rosacea

Last checked: Nov 19, 2026Latest source record: Sep 16, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 140 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

140

Actual

Start

Jul 2, 2018

Primary completion

Feb 11, 2019

Study completion Mar 5, 2019

Sponsor

Lead sponsor
AOBiome LLCIndustry
Sponsor type
Industry
Collaborators
bioRASI, LLC
First posted
Jul 18, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized Phase II trial, comparing the effect of twice daily B244 application for 8 weeks vs. vehicle application on treatment of mild to moderate rosacea.

Conditions

  • Rosacea

Interventions

  • B244Biological

    B244 Suspension

  • VehicleBiological

    Vehicle suspension

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0Time frame: Baseline to Day 84

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Tampa Bay Medical Research

    Clearwater, Florida

  • Veritas Research Corp

    Miami, Florida

  • South Coast Research Center, Inc.

    Miami, Florida

  • FXM Research Corp.

    Miami, Florida

  • FXM Research Miramar

    Miramar, Florida

  • Wake Research Associates, LLC

    Raleigh, North Carolina

  • Paddington Testing Co.

    Philadelphia, Pennsylvania

  • Omega Medical Research

    Warwick, Rhode Island

  • West Houston Clinical Research Service

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.